Pharmaceutical - Antibiotics and Infectious diseases, Anti-Arthritics/Rheumatics

Filter

Popular Filters

Briefs: Added use for Theravance's Vibativ; approval sought for ViiV dolutegravir; FDA accepts Pfizer sNDA for Xeljanz

23-06-2013

USA-based Theravance (Nasdaq: THRX) says that the US Food and Drug Administration has approved the firm's…

Anti-Arthritics/RheumaticsAnti-viralsAntibiotics and Infectious diseasesBiotechnologydolutegravirNorth AmericaPfizerPharmaceuticalRegulationTheravanceVibativViiV HealthcareXeljanz

Company Spotlight

ImmunoGen

ImmunoGen

Back to top